Immediate Versus Delayed Insertion of the Copper IUD After Second-trimester Medical Abortion - a Randomised Controlled Trial.
| Registry | NCT03505047 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 110 (Actual) |
| Sponsor | University of Cape Town (Other); collaborators: University of California, San Francisco |
| Conditions | Contraception |
| Interventions | Copper Intrauterine device (Device) |
| Dates | start 2018-05-10, primary completion 2019-08-31, completion 2020-01-31, first posted 2018-04-23, last updated 2020-03-26 |
| Locations | 1 site in South Africa |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Contraception All trials of Copper Intrauterine device
The main objective of the study is to compare use, in a randomised controlled trial, of the the copper IUD if inserted immediately after completion of a second trimester medical abortion, to standard care with insertion 3-4 or more weeks after abortion at community health centres.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Immediate group: | Experimental | Device: Copper Intrauterine device | The Copper Intrauterine device will be inserted within 24 hours of the expulsion of the fetus and placenta or after surgical evacuation for placental remains, and prior to discharge from the facility. |
| Delayed Group | No intervention | The Copper Intrauterine device will be inserted at a local community health centre 14-28 days after discharge. |
Sex: Female, ages: 18 Years to any
Inclusion Criteria: * Able to speak English, Afrikaans or Xhosa; * Requesting and eligible for abortion according to standard practice at the hospital; * Gestational age 13-20 weeks verified by ultrasound; * Interested and eligible for the copper IUD as a post-abortion contraceptive method; * Willingness to participate in the trial including follow-up; * Able to provide a working phone \& telephone number to allow for contact; * Willing and able to provide informed consent * Staying within one hour travel time of GSH Exclusion Criteria: * Active pelvic inflammatory disease, pelvic tuberculosis; severe thrombocytopenia; * Positive N. Gonorrhea or C. Trachomatis that has not been adequately treated * Copper allergy * Hb <10g/dL * Uterine anomaly preventing placement of the IUD; cervical cancer or carcinoma in-situ, untreated high grade squamous intraepithelial lesions * Hemorrhage; or ruptured uterus * History of ectopic pregnancy * Wilsons' disease
| Facility | City | Country | Status |
|---|---|---|---|
| Groote Schuur Hospital | Cape Town, Western Province | South Africa |